Combining the resources and expertise of seven institutions in North America and Europe, the research program will offer insights into the molecular workings of heart muscle cells and how genetic mutations affect their function.Continue reading
Author Archive: AZBio
It’s Not Always Easy To Do What’s Right
A guest post by Representative Heather Carter, Chair of the Health and Human Services Committee, Arizona House of Representatives.Continue reading
MSDx, Inc. Awarded a Rapid Response Innovation Grant
MSDx, Inc. Awarded a Rapid Response Innovation Grant from The Michael J. Fox Foundation For the Development of Biomarkers in Parkinson’s DiseaseContinue reading
BIO Statement On U.S. Supreme Court Review Of Isolated DNA Patents
Washington, D.C. (June 13, 2013)
Jim Greenwood, President and CEO of the Biotechnology Industry Organization (BIO), today issued the following statement on the U.S. Supreme Court’s decision regarding Myriad Genetics’ patent claims on isolated DNA molecules: Continue reading
MSDx seeks USD 5m first VC round for blood-based multiple sclerosis monitoring assay, CEO says
BioPharm Insight Profiles MSDxContinue reading
RiboMed and AIT Partner on Epigenetic Tests for Early Lung Cancer Detection
RiboMed and Austrian Institute of Technology Partner on Epigenetic Tests for Early Lung Cancer Detection, Sub-typing and Drug Response.Continue reading
New AdvaMed White Paper Affirms FDA’s 510(k) Change Guidance
Only Targeted Improvements NeededContinue reading
Brain Parasite Has Potential to Unlock Neurobiology Secrets
Dr. Anita Koshy sees a common and typically harmless brain parasite as a potential key to unlocking secrets of neurobiology that can be used to intervene in diseases such as Alzheimer’s and multiple sclerosis.Continue reading
Biotech Crops vs. Pests: Successes, Failures From the First Billion Acres
A new global assessment helps scientists explain why genetically modified crops have suppressed some pests for longer than a decade, while others adapted in a few years.Continue reading
CRITICAL PATH INSTITUTE ANNOUCES NEW CONSORTIUM EXECUTIVE DIRECTOR
Dr. John-Michael Sauer, a 15-year veteran of pharmaceutical research and development, will lead the Predictive Safety Testing ConsortiumContinue reading